Inventor · disambiguated record
Brent Blackburn
Also filed as: BLACKBURN BRENT · BLACKBURN BRENT K
24 granted patents·14 pending applications·490 citations·filing 1992–2013
96Inventor score
Files withCV THERAPEUTICS INC15GENENTECH INC11BELARDINELLI LUIZ5BLACKBURN BRENT2GILEAD PALO ALTO INC2
Top patents by PatentIndex Score
38 records- 0196US6552023B2Aralkyl substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Apr 22, 2003·64 cites·24 claims
- 0295US6677336B2Substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Jan 13, 2004·59 cites·34 claims
- 0394US6677342B2Partial fatty acid oxidation inhibitors in the treatment of congestive heart failureCV THERAPEUTICS INC·Filed 2002·Granted Jan 13, 2004·72 cites·20 claims
- 0493US7582617B2Myocardial perfusion imaging methodCV THERAPEUTICS INC·Filed 2005·Granted Sep 1, 2009·27 cites·22 claims
- 0592US6451798B2Substituted alkyl piperazine derivativesCV THERAPEUTICS INC·Filed 2001·Granted Sep 17, 2002·26 cites·26 claims
- 0689US5565449ANonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptorGENENTECH INC·Filed 1995·Granted Oct 15, 1996·42 cites·7 claims
- 0787US8536150B2Methods of myocardial perfusion imagingBELARDINELLI LUIZ·Filed 2012·Granted Sep 17, 2013·5 cites·3 claims
- 0887US6599283B1Method of preventing reperfusion injuryCV THERAPEUTICS INC·Filed 2001·Granted Jul 29, 2003·53 cites·10 claims
- 0987US5403836ABenzazepine platelet aggregation inhibitors having specificity for the GPIIb IIIa receptorGENENTECH INC·Filed 1993·Granted Apr 4, 1995·34 cites·10 claims
- 1086US6528511B2Partial fatty acid oxidation inhibitors in the treatment of congestive heart failureCV THERAPEUTICS INC·Filed 2001·Granted Mar 4, 2003·22 cites·35 claims
- 1184US6677343B2Substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Jan 13, 2004·15 cites·25 claims
- 1283US8071566B2Methods of coronary imagingBELARDINELLI LUIZ·Filed 2009·Granted Dec 6, 2011·6 cites·13 claims
- 1369US5674863ANonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptorGENENTECH INC·Filed 1995·Granted Oct 7, 1997·11 cites·7 claims
- 1469US5663166ANonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptorGENENTECH INC·Filed 1995·Granted Sep 2, 1997·11 cites·7 claims
- 1566US5674865ANonpeptidyl integrin inhibitors having specificity for the GPIIb IIIaGENENTECH INC·Filed 1995·Granted Oct 7, 1997·9 cites·7 claims
- 1666US5250679ANonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptorGENENTECH INC·Filed 1992·Granted Oct 5, 1993·19 cites·1 claims
- 1765US2008109040A1Method of treating arrhythmiasBELARDINELLI LUIZ·Filed 2007·Application pending·0 cites
- 1863US9163057B2Methods of myocardial perfusion imagingGILEAD SCIENCES INC·Filed 2013·Granted Oct 20, 2015·0 cites·5 claims
- 1963US2010086483A1Method of multidetector computed tomagraphyGILEAD PALO ALTO INC·Filed 2009·Application pending·0 cites
- 2059US2009081120A1Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging MethodsCV THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 2159US2010004255A1Method of treating arrhythmiasBELARDINELLI LUIZ·Filed 2009·Application pending·0 cites
- 2258US2009176772A1Method of reversing left ventricular remodelingBLACKBURN BRENT·Filed 2009·Application pending·0 cites
- 2351US6852723B2Aralkyl substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2003·Granted Feb 8, 2005·0 cites·18 claims
- 2450US7776868B2Substituted bicyclic and tricyclic thieno[2,3-d]pyrimidines as A2A adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2007·Granted Aug 17, 2010·0 cites·13 claims
- 2550US2006111361A1Method of reversing left ventricle remodelingBLACKBURN BRENT·Filed 2005·Application pending·0 cites
- 2650US2004137533A1Method of identifying partial agonists of the A2A receptorCV THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 2749US5716951ATricyclic inhibitors of the vitronectin receptorGENENTECH INC·Filed 1995·Granted Feb 10, 1998·3 cites·7 claims
- 2849US5705890ATricyclic inhibitors of the GPIIb IIIa receptorGENENTECH INC·Filed 1994·Granted Jan 6, 1998·6 cites·13 claims
- 2947US2003064994A1Substituted alkyl piperazine derivativesCV THERAPEUTICS INC·Filed 2002·Application pending·0 cites
- 3047US2003220344A1Method of treating arrhythmiasFiled 2003·Application pending·0 cites
- 3146US7109326B2Halo-alkoxycarbonyl prodrugsGENENTECH INC·Filed 2004·Granted Sep 19, 2006·0 cites·5 claims
- 3246US2008170990A1Methods for Myocardial Imaging in Patients Having a History of Pulmonary DiseaseCV THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3345US2002012946A1Method of identifying partial agonists of the A2A receptorFiled 2001·Application pending·0 cites
- 3445US2008213165A1Methods and Compositions for Increasing Patent Tolerability During Myocardial Imaging MethodsCV THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3545US2012046299A1Method of treating arrhythmiasBELARDINELLI LUIZ·Filed 2011·Application pending·0 cites
- 3641US6576619B2Orally active A1 adenosine receptor agonistsCV THERAPEUTICS INC·Filed 1999·Granted Jun 10, 2003·4 cites·22 claims
- 3738US5493020ATricyclic inhibitors of the GPIIb IIIa receptorGENENTECH INC·Filed 1993·Granted Feb 20, 1996·2 cites·5 claims
- 3830US2001020019A1Novel halo-alkoxycarbonyl prodrugsGENENTECH INC·Filed 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brent Blackburn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →